FIELD: medicine.
SUBSTANCE: new derivatives of diphenyl urea having general formula I or their pharmaceutically comprehensible salts, where Ro - hydrogen are described; Rm - hydrogen or trifluoromethyl; Rp - hydrogen, halogeno, trifluoromethyl, trifluoromethoxy, C1-6alkyl or C1-6alkoxy; provided that Ro, Rm and Rp simultaneously cannot mean hydrogen; R2, R3, R4 and R5 independently mean hydrogen, halogeno or trifluoromethyl, provided that the bond does not represent N-(3-trifluoromethyl-phenyl)-N'-[3-(1N-tetrazole-5-il)-4'-trifluoromethyl-biphenyl-4-il]-urea, a pharmaceutical composition, their containing, and their application as blockers of chloride channels.
EFFECT: rising of efficiency of a composition and its application in medicine.
12 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
DERIVATIVES OF AMINOINDAZOLS AND THEIR APPLICATION AS KINASES INHIBITORS | 2003 |
|
RU2339624C2 |
2-(PHENYL OR PYRID-3-YL)AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATING KINASE 2 (LRRK2) FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2647849C2 |
METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
NOVEL BENZIMIDAZOLE DERIVATIVES AND BASED ON THEM PHARMACEUTICAL COMPOSITION, FOR APPLICATION IN TREATMENT OF VR1-MEDIATED DISORDERS | 2004 |
|
RU2337098C2 |
SUBSTITUTED PHENYL DERIVATIVES, THEIR PREPARING AND APPLICATION | 1999 |
|
RU2218328C2 |
OESTROGEN RECEPTORS LIGANDS | 2012 |
|
RU2620375C9 |
NEW BICYCLIC COMPOUNDS AS DUAL INHIBITORS OF ATX/CA | 2016 |
|
RU2724899C2 |
PURINYL DERIVATIVES AND USE THEREOF AS POTASSIUM CHANNEL MODULATORS | 2008 |
|
RU2468026C2 |
3-AMINO-PYRIDINE DERIVATIVES FOR TREATING METABOLIC DISORDERS | 2007 |
|
RU2460729C2 |
Authors
Dates
2009-03-27—Published
2004-06-15—Filed